The Delta Variant and Low Vaccine Rates Could Spell Trouble

CureVac’s Covid-19 Vaccine Disappoints in Clinical Trial

How Emergent BioSolutions Earned Profits But Delivered Disappointing Vaccine Returns

We have another highly effective COVID vaccine, based on different tech. While not needed for the US, it should help with the global vaccine push.